RU95121731A - Применение рилузола для лечения нейро-спида и способ получения лекарственного средства - Google Patents
Применение рилузола для лечения нейро-спида и способ получения лекарственного средстваInfo
- Publication number
- RU95121731A RU95121731A RU95121731/14A RU95121731A RU95121731A RU 95121731 A RU95121731 A RU 95121731A RU 95121731/14 A RU95121731/14 A RU 95121731/14A RU 95121731 A RU95121731 A RU 95121731A RU 95121731 A RU95121731 A RU 95121731A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- neuro
- aids
- riluzol
- medicine
- Prior art date
Links
- FTALBRSUTCGOEG-UHFFFAOYSA-N Riluzole Chemical compound C1=C(OC(F)(F)F)C=C2SC(N)=NC2=C1 FTALBRSUTCGOEG-UHFFFAOYSA-N 0.000 title claims 4
- 238000004519 manufacturing process Methods 0.000 title claims 4
- 206010000565 Acquired immunodeficiency syndrome Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 claims 3
- 229960004181 riluzole Drugs 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 229940079593 drugs Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- 206010057668 Cognitive disease Diseases 0.000 claims 1
- 241000713772 Human immunodeficiency virus 1 Species 0.000 claims 1
- 206010061284 Mental disease Diseases 0.000 claims 1
- 206010028640 Myopathy Diseases 0.000 claims 1
- 206010060860 Neurological symptom Diseases 0.000 claims 1
- 206010029331 Neuropathy peripheral Diseases 0.000 claims 1
- 206010047518 Vision disease Diseases 0.000 claims 1
- 206010047541 Visual disorder Diseases 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010770 muscular disease Diseases 0.000 claims 1
Claims (4)
1. Применение рилузола для фармацевтически приемлемых солей этого соединения для получения лекарственных средств, предназначенных для лечения нейро-СПИДА.
2. Применение по п. 1 для получения лекарственных средств, предназначенных для лечения умственных расстройств, расстройств способности к познанию, невропатий, миопатий, расстройств зрения и любых неврологических симптомов, связанных с вирусом ВИЧ-1.
3. Применение по п. 1 для получения лекарственного средства, содержащего 25-200 мг рилузола.
4. Способ получения лекарственного средства, полезного при лечении нейро-СПИДА, отличающийся тем, что смешивают рилузол или фармацевтически приемлемую соль этого соединения с одним или несколькими разбавителями и/или вспомогательными веществами, совместимыми и фармацевтически приемлемыми.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9302568A FR2702148B1 (fr) | 1993-03-05 | 1993-03-05 | Application d'anticonvulsivants dans le traitement du neuro-sida. |
FR9302568 | 1993-03-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95121731A true RU95121731A (ru) | 1997-10-10 |
RU2157205C2 RU2157205C2 (ru) | 2000-10-10 |
Family
ID=9444690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95121731/14A RU2157205C2 (ru) | 1993-03-05 | 1994-02-25 | Применение рилузола для лечения нейро-спида и способ получения лекарственного средства |
Country Status (23)
Country | Link |
---|---|
US (2) | US5629312A (ru) |
EP (3) | EP0687176B1 (ru) |
JP (3) | JPH08507508A (ru) |
KR (3) | KR960700721A (ru) |
AT (2) | ATE147981T1 (ru) |
AU (3) | AU6143894A (ru) |
CA (3) | CA2154571A1 (ru) |
CZ (3) | CZ284423B6 (ru) |
DE (2) | DE69427344T2 (ru) |
DK (2) | DK0687177T3 (ru) |
ES (2) | ES2157252T3 (ru) |
FR (1) | FR2702148B1 (ru) |
GR (2) | GR3022356T3 (ru) |
HU (3) | HUT73434A (ru) |
IL (3) | IL108845A0 (ru) |
NO (3) | NO953372L (ru) |
PL (3) | PL310474A1 (ru) |
PT (1) | PT687176E (ru) |
RU (1) | RU2157205C2 (ru) |
SK (3) | SK107595A3 (ru) |
UA (1) | UA41355C2 (ru) |
WO (3) | WO1994020103A1 (ru) |
ZA (2) | ZA941530B (ru) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5866597A (en) * | 1993-03-19 | 1999-02-02 | Glaxo Wellcome Inc. | Use of triazine compounds for the treatment of memory and learning disorders |
GB9424766D0 (en) * | 1994-12-07 | 1995-02-08 | Wellcome Found | Pharmaceutical composition |
GB9512854D0 (en) * | 1995-06-23 | 1995-08-23 | Wellcome Found | Novel formulation |
DE19603984A1 (de) * | 1996-02-05 | 1997-08-07 | Bayer Ag | Granulate von Triazinen |
US20020022056A1 (en) | 1997-02-14 | 2002-02-21 | Burkhard Schlutermann | Oxacarbazepine film-coated tablets |
CO4920215A1 (es) * | 1997-02-14 | 2000-05-29 | Novartis Ag | Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones |
US5922746A (en) * | 1997-03-27 | 1999-07-13 | Allergan | Inhibition of noninactivating Na channels of mammalian optic nerve as a means of preventing optic nerve degeneration associated with glaucoma |
GB9721497D0 (en) * | 1997-10-09 | 1997-12-10 | Ciba Geigy Ag | Organic compounds |
FR2774592B1 (fr) * | 1998-02-06 | 2000-03-17 | Rhone Poulenc Rorer Sa | Application du 2-amino-6-trifluoromethoxybenzothiazole pour la prevention ou le traitement des dysfonctionnements du cervelet |
FR2774908B1 (fr) * | 1998-02-17 | 2000-06-23 | Centre Nat Rech Scient | Utilisation d'inhibiteur de la liberation du glutamate dans le traitement de l'ischemie retinienne |
FR2787028B1 (fr) * | 1998-12-15 | 2002-10-18 | Aventis Pharma Sa | Utilisation du riluzole dans le traitement des traumatismes acoustiques |
AU4424500A (en) * | 1999-04-29 | 2000-11-17 | Centre National De La Recherche Scientifique (C.N.R.S.) | A method for the prevention of ischemic spinal cord injury caused by aortic crossclamping |
US7479498B2 (en) | 1999-08-23 | 2009-01-20 | Phoenix Biosciences, Inc. | Treatments for viral infections |
GB9925962D0 (en) * | 1999-11-02 | 1999-12-29 | Novartis Ag | Organic compounds |
FR2801217B1 (fr) * | 1999-11-24 | 2002-12-06 | Aventis Pharma Sa | Association de riluzole et de gabapentine et son utilisation comme medicament |
GB9930058D0 (en) | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
US6207179B1 (en) * | 2000-05-18 | 2001-03-27 | Phoenix Scientific, Inc. | Parasiticidal formulation for animals and a method of making this formulation |
CA2471666C (en) | 2004-06-18 | 2009-10-13 | Apotex Pharmachem Inc. | An improved process for the preparation of oxcarbazepine and related intermediates |
EP1874353A1 (en) * | 2005-04-05 | 2008-01-09 | Yale University | Glutamate modulating agents in the treatment of mental disorders |
US20060252745A1 (en) * | 2005-05-06 | 2006-11-09 | Almeida Jose L D | Methods of preparing pharmaceutical compositions comprising eslicarbazepine acetate and methods of use |
FR2910811B1 (fr) * | 2007-01-03 | 2009-07-10 | Ass Pour Le Dev De La Biothera | Utilisation du riluzole et de ses derives pour fabriquer de nouveaux medicaments |
GB0700773D0 (en) | 2007-01-15 | 2007-02-21 | Portela & Ca Sa | Drug therapies |
FR2957077B1 (fr) * | 2010-03-02 | 2012-04-13 | Univ Dauvergne Clermont I | Utilisation du riluzole pour traiter ou prevenir les effets indesirables d'agents anti-cancereux |
KR102580378B1 (ko) * | 2014-11-21 | 2023-09-19 | 바이오하벤 파마슈티컬 홀딩 컴퍼니 엘티디. | 릴루졸의 설하 제제 |
CA3209488A1 (en) * | 2021-02-24 | 2022-09-01 | Jacob BONTA | Foaming evaporator coil cleaner |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2492258A1 (fr) * | 1980-10-17 | 1982-04-23 | Pharmindustrie | Nouveau medicament a base d'amino-2 trifluoromethoxy-6 benzothiazole |
US4431641A (en) * | 1980-10-17 | 1984-02-14 | Ciba-Geigy Corporation | Pharmaceutical compositions having antiepileptic and antineuralgic action |
GB8613183D0 (en) * | 1986-05-30 | 1986-07-02 | Wellcome Found | Triazine salt |
US4826860A (en) * | 1987-03-16 | 1989-05-02 | Warner-Lambert Company | Substituted 2-aminobenzothiazoles and derivatives useful as cerebrovascular agents |
US4918090A (en) * | 1988-01-25 | 1990-04-17 | Warner-Lambert Company | Substituted 2-aminbenzothiazoles and derivatives useful as cerebrovascular agents |
EP0435826A1 (de) * | 1989-12-27 | 1991-07-03 | Ciba-Geigy Ag | Intravenöse Lösungen für Status Epilepticus |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
FR2688138B1 (fr) * | 1992-03-06 | 1995-05-05 | Rhone Poulenc Rorer Sa | Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique. |
JPH07308499A (ja) * | 1994-05-20 | 1995-11-28 | Brother Ind Ltd | 衣類乾燥機 |
-
1993
- 1993-03-05 FR FR9302568A patent/FR2702148B1/fr not_active Expired - Lifetime
-
1994
- 1994-02-25 PL PL94310474A patent/PL310474A1/xx unknown
- 1994-02-25 CA CA002154571A patent/CA2154571A1/fr not_active Abandoned
- 1994-02-25 PL PL94310475A patent/PL310475A1/xx unknown
- 1994-02-25 SK SK1075-95A patent/SK107595A3/sk unknown
- 1994-02-25 CZ CZ952261A patent/CZ284423B6/cs unknown
- 1994-02-25 JP JP6519648A patent/JPH08507508A/ja active Pending
- 1994-02-25 JP JP6519649A patent/JPH08507509A/ja active Pending
- 1994-02-25 PL PL94310476A patent/PL310476A1/xx unknown
- 1994-02-25 EP EP94908374A patent/EP0687176B1/fr not_active Expired - Lifetime
- 1994-02-25 SK SK1076-95A patent/SK279659B6/sk not_active IP Right Cessation
- 1994-02-25 PT PT94908374T patent/PT687176E/pt unknown
- 1994-02-25 AT AT94908376T patent/ATE147981T1/de active
- 1994-02-25 EP EP94908376A patent/EP0687177B1/fr not_active Expired - Lifetime
- 1994-02-25 HU HU9502583A patent/HUT73434A/hu unknown
- 1994-02-25 AU AU61438/94A patent/AU6143894A/en not_active Abandoned
- 1994-02-25 SK SK1074-95A patent/SK107495A3/sk unknown
- 1994-02-25 HU HU9502584A patent/HU9502584D0/hu unknown
- 1994-02-25 WO PCT/FR1994/000208 patent/WO1994020103A1/fr active IP Right Grant
- 1994-02-25 DE DE69427344T patent/DE69427344T2/de not_active Expired - Lifetime
- 1994-02-25 DK DK94908376.0T patent/DK0687177T3/da active
- 1994-02-25 AU AU61439/94A patent/AU675119B2/en not_active Ceased
- 1994-02-25 HU HU9502585A patent/HU217132B/hu not_active IP Right Cessation
- 1994-02-25 CZ CZ952259A patent/CZ285339B6/cs not_active IP Right Cessation
- 1994-02-25 CA CA002154573A patent/CA2154573A1/fr not_active Abandoned
- 1994-02-25 EP EP94908375A patent/EP0687179A1/fr not_active Withdrawn
- 1994-02-25 DK DK94908374T patent/DK0687176T3/da active
- 1994-02-25 WO PCT/FR1994/000209 patent/WO1994020110A1/fr not_active Application Discontinuation
- 1994-02-25 ES ES94908374T patent/ES2157252T3/es not_active Expired - Lifetime
- 1994-02-25 AU AU61437/94A patent/AU675118B2/en not_active Ceased
- 1994-02-25 UA UA95083996A patent/UA41355C2/ru unknown
- 1994-02-25 ES ES94908376T patent/ES2096455T3/es not_active Expired - Lifetime
- 1994-02-25 CA CA002154572A patent/CA2154572C/fr not_active Expired - Fee Related
- 1994-02-25 JP JP51964794A patent/JP3578174B2/ja not_active Expired - Fee Related
- 1994-02-25 CZ CZ952260A patent/CZ226095A3/cs unknown
- 1994-02-25 DE DE69401577T patent/DE69401577T2/de not_active Expired - Fee Related
- 1994-02-25 AT AT94908374T patent/ATE201597T1/de active
- 1994-02-25 US US08/530,253 patent/US5629312A/en not_active Expired - Fee Related
- 1994-02-25 KR KR1019950703734A patent/KR960700721A/ko not_active Application Discontinuation
- 1994-02-25 KR KR1019950703733A patent/KR960700723A/ko not_active Application Discontinuation
- 1994-02-25 KR KR1019950703732A patent/KR100318168B1/ko not_active IP Right Cessation
- 1994-02-25 RU RU95121731/14A patent/RU2157205C2/ru not_active IP Right Cessation
- 1994-02-25 WO PCT/FR1994/000210 patent/WO1994020108A1/fr active IP Right Grant
- 1994-03-03 IL IL10884594A patent/IL108845A0/xx unknown
- 1994-03-03 IL IL10884694A patent/IL108846A0/xx not_active IP Right Cessation
- 1994-03-03 IL IL108844A patent/IL108844A/en not_active IP Right Cessation
- 1994-03-04 ZA ZA941530A patent/ZA941530B/xx unknown
- 1994-03-04 ZA ZA941525A patent/ZA941525B/xx unknown
-
1995
- 1995-02-28 US US08/396,106 patent/US5624945A/en not_active Expired - Lifetime
- 1995-08-28 NO NO953372A patent/NO953372L/no unknown
- 1995-08-28 NO NO953370A patent/NO307687B1/no not_active IP Right Cessation
- 1995-08-28 NO NO953371A patent/NO953371L/no unknown
-
1997
- 1997-01-23 GR GR960402768T patent/GR3022356T3/el unknown
-
2001
- 2001-05-31 GR GR20010400060T patent/GR3035957T3/el unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95121731A (ru) | Применение рилузола для лечения нейро-спида и способ получения лекарственного средства | |
RU95114405A (ru) | Применение рилузола в качестве лекарственного средства для лечения неврологических нарушений, вызванных травмами и способ получения лекарственного средства | |
KR960700716A (ko) | Aids-관련 신경 장애를 치료하기 위한 리루졸의 사용(use of riluzole for treating aids-related neural disorders) | |
NL970006I1 (nl) | Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson. | |
BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
HUP0203325A2 (hu) | Biciklusos aminosavak, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
KR930007441A (ko) | 의약품 | |
CA2004239A1 (en) | Use of acetyl d-carnitine in the therapeutic treatment of glaucoma, and pharmaceutical compositions useful in such treatment | |
ZA898667B (en) | Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment | |
RU95101385A (ru) | Продукты, содержащие g-csf и tnf связующие протеина | |
JP3018160B2 (ja) | 月経困難症及び/又は月経前症候群の軽減用薬剤 | |
JP2006083190A (ja) | 手術後の悪心および嘔吐の治療のためのグラニセトロンの使用 | |
ATE159427T1 (de) | Anwendung des n-n-butyl-derivates von desoxynojirimycin zur herstellung eines arzneimittels zur inhibierung von hiv-virus | |
EP0600582B1 (en) | Treatment for muscular dystrophy | |
RU95121732A (ru) | Применение ламотригина для лечения нейро-спида и способ получения лекарственного средства | |
IT1276462B1 (it) | Diamidi aromatiche acide ad attivita' antigastrinica, procedimento per la loro preparazione e loro uso farmaceutico | |
RU97104062A (ru) | Применение селегилина для лечения эпилептических заболеваний | |
DE3688787D1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
KR910007528A (ko) | 벤조디아제핀 및 페닐피릴케톤 유도체의 용도 | |
WO2000043014A8 (en) | Beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine for use in the treatment of hiv infections | |
RU93037431A (ru) | Энтерсорбент для выведения депонированных в организме радионуклидов | |
RU95115404A (ru) | Применение рилузола в качестве средства для лечения болезни паркинсона и синдромов паркинсона, способ получения лекарственного средства | |
EP0256629A2 (en) | Tolrestat or a salt thereof as an immuno-stimulating agent | |
US5081129A (en) | Method of treatment of anemia with seratonin antagonists | |
Dirschl et al. | Patellar overgrowth after infection of the knee. A case report. |